These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6928047)

  • 1. Nonmutational alteration in glucocorticoid sensitivity of lymphosarcoma P1798.
    Davis JM; Chan AK; Thompson EA
    J Natl Cancer Inst; 1980 Jan; 64(1):55-62. PubMed ID: 6928047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid effects of lymphosarcoma P1798 on DNA replication and growth of subcutaneous tumors in mice.
    Thompson EA; Moore WM; Sawyer RH
    J Natl Cancer Inst; 1980 Aug; 65(2):477-83. PubMed ID: 6931263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid receptors and mechanism of resistance in the cortisol-sensitive and -resistant lines of lymphosarcoma P1798.
    Kaiser N; Milholland RJ; Rosen F
    Cancer Res; 1974 Mar; 34(3):621-6. PubMed ID: 4359883
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of glucocorticoid hormones in vitro on the structural integrity of nuclei in corticosteroid-sensitive and -resistant lines of lymphosarcoma P1798.
    Nicholson ML; Young DA
    Cancer Res; 1978 Nov; 38(11 Pt 1):3673-80. PubMed ID: 581273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear binding of steroid-receptor complex to lymphosarcoma P1798 resistant and sensitive cells and effect of concanavalin A on receptor levels.
    McPartland RP; Milholland RJ; Rosen F
    Cancer Res; 1977 Dec; 37(12):4256-60. PubMed ID: 579163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid binding properties of mouse thymic lymphosarcoma cell populations selected for resistance to the cytolytic effects of glucocorticoids in vivo.
    Chan AK; Thompson EA
    J Natl Cancer Inst; 1983 Sep; 71(3):579-82. PubMed ID: 6577232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insensitivity to the cytolytic effects of glucocorticoids in vivo is associated with a novel "slow death" phenotype.
    Thompson EA
    Cancer Res; 1991 Oct; 51(20):5544-50. PubMed ID: 1913673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteins associated with emergence of the resistance to lethal glucocorticoid actions in P1798 mouse lymphosarcoma cells.
    Nicholson ML; Voris BP; Young DA
    Cancer Res; 1981 Sep; 41(9 Pt 1):3530-7. PubMed ID: 6894886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell membrane sialoglycopeptides of corticoid-sensitive and -resistant lymphosarcoma P1798.
    Behrens UJ; Hollander VP
    Cancer Res; 1976 Jan; 36(1):172-80. PubMed ID: 946164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The truncated glucocorticoid receptor in the P1798 mouse lymphosarcoma is associated with resistance to glucocorticoid lysis but not to other glucocorticoid-induced functions.
    Ip MM; Shea WK; Sykes D; Young DA
    Cancer Res; 1991 Jun; 51(11):2786-96. PubMed ID: 1674446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and molecular characterization of the glucocorticoid receptor of lymphosarcoma P1798 variants.
    Lucas KL; Barbour KW; Housley PR; Thompson EA
    Mol Endocrinol; 1988 Mar; 2(3):291-9. PubMed ID: 3398856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early effects of glucocorticoid treatment on amino acid metabolism in lymphosarcoma P1798.
    Stevens J; Stevens YW; Hollander VP
    Cancer Res; 1973 Feb; 33(2):370-4. PubMed ID: 4739450
    [No Abstract]   [Full Text] [Related]  

  • 13. Independence of the lethal actions of glucocorticoids on lymphoid cells from possible hormone effects on calcium uptake.
    Nicholson ML; Young DA
    J Supramol Struct; 1979; 10(2):165-74. PubMed ID: 582325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of cortisol-sensitive and -resistant P1798 mouse lymphosarcoma cell lines.
    Chi CW; Sykes D; Ip MM
    Mol Cell Endocrinol; 1989 Apr; 62(2):167-76. PubMed ID: 2744225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapy with 5-azacytidine and hydrocortisone in glucocorticoid-sensitive and -resistant mouse P1798 lymphosarcoma.
    Chi CW; Ip MM
    J Natl Cancer Inst; 1988 Aug; 80(12):912-8. PubMed ID: 2456400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of transformed mouse keratinocytes to growth inhibition by glucocorticoids.
    Spiegelman VS; Budunova IV; Carbajal S; Slaga TJ
    Mol Carcinog; 1997 Sep; 20(1):99-107. PubMed ID: 9328440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of lymphosarcoma P1798 variants selected for resistance to the cytolytic effects of glucocorticoids in vivo and in culture.
    Wood KM; Thompson EA
    Mol Cell Endocrinol; 1984 Sep; 37(2):169-80. PubMed ID: 6092172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid insensitivity of P1798 lymphoma cells is associated with production of a factor that attenuates the lytic response.
    Thompson EA
    Cancer Res; 1991 Oct; 51(20):5551-6. PubMed ID: 1913674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro growth stimulation of murine hepatoma cells by glucocorticoid.
    Lui WY; Chi CW; Chang YF; Chu HW; Hsieh CC; Yin PH; Liu TY; Ou YR; P'eng FK
    Anticancer Res; 2002; 22(3):1413-22. PubMed ID: 12168818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sodium butyrate on glucocorticoid-sensitive and -resistant P1798 lymphosarcoma.
    Chang YF; Wu LH; Liu TY; Yang JC; Chi CW
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jan; 49(1):1-5. PubMed ID: 1312378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.